Cochrane Abstracts
GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"GenoType® MTBDRsl Assay for Resistance to Second‐line Anti‐tuberculosis Drugs." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431351/all/GenoType®_MTBDRsl_assay_for_resistance_to_second‐line_anti‐tuberculosis_drugs_Unchanged.
GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431351/all/GenoType®_MTBDRsl_assay_for_resistance_to_second‐line_anti‐tuberculosis_drugs_Unchanged. Accessed July 17, 2025.
GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431351/all/GenoType®_MTBDRsl_assay_for_resistance_to_second‐line_anti‐tuberculosis_drugs_Unchanged
GenoType® MTBDRsl Assay for Resistance to Second‐line Anti‐tuberculosis Drugs [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 July 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431351/all/GenoType®_MTBDRsl_assay_for_resistance_to_second‐line_anti‐tuberculosis_drugs_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs
ID - 431351
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431351/all/GenoType®_MTBDRsl_assay_for_resistance_to_second‐line_anti‐tuberculosis_drugs_Unchanged
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
